The Claim
Advancing liver fibrosis in adults with metabolic dysfunction-associated steatotic liver disease is associated with an increased incidence of cardiovascular events.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults with metabolic dysfunction-associated steatotic liver disease, more severe liver scarring is linked to a higher rate of heart attacks and other cardiovascular events.
See the scientific wording
Cardiovascular events increase with advancing liver fibrosis in adults with metabolic dysfunction-associated steatotic liver disease, suggesting that liver disease severity may be a key factor in cardiovascular risk stratification.
As the liver scars, it releases inflammatory signals that travel through the blood, damaging the lining of blood vessels and making them more likely to form clots and blockages.
What the research says
1 studyIn people with fatty liver disease, the worse their liver scarring gets, the more likely they are to have heart attacks or strokes — and regular heart risk tools miss this link. This study shows that liver damage is a hidden factor that raises heart disease risk.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.